Editors


Matthew Bohlsen

About Matthew Bohlsen

Matthew Bohlsen is a Senior Editor for InvestorIntel.com. With a Graduate Diploma in Applied Finance and Investment, and a Graduate Diploma in Financial Planning. He has 30 years of personal investing experience, and 20 years of professional investing experience. As a global investor he uses a macro thematic approach searching for high growth areas. Some trends he currently follows include the rising Asian middle class, electric vehicles and the lithium/cobalt/graphite/nickel/copper/vanadium miners, renewable energy, energy storage (including vanadium), personal robots, the online data boom and autonomous vehicles.

623 InvestorIntel Articles By Matthew Bohlsen

image_pdfimage_print

Matt Bohlsen’s Top picks in defense, aviation, and related ETFs for 2022

As we start 2022 one area of concern is global geopolitical uncertainty. In particular, Russia continues to threaten Ukraine, and […]


Matt Bohlsen’s Top 3 stock picks for 2022’s EV Boom

2021 was a landmark year for electric vehicles (EVs) with global sales likely to end about 100% higher at around […]


Neo Performance Materials looks to expand capacity as it rides the tailwind of growing rare earth permanent magnet demand

Demand for rare earth metals and magnets has been very strong in 2021, boosted by an approximate 100% surge in […]


Which Metals will benefit from the EV Boom in 2022 and after?

2021 has been a triumphant year for electric vehicle (EV) metal miner stocks. This is because EV sales are on […]


The Top 5 graphite miners to watch in 2022 as battery materials’ prices rise

2021 has seen key electric vehicle (“EV”) and battery metals lithium, cobalt, nickel, and neodymium/praseodymium (NdPr) prices all rise strongly. […]


For Mas Gold its all focused towards gold production in Saskatchewan…

[Co-Publisher Note: This story was written prior to the news release that came out at market open today. To access […]


Awakn Life Sciences’ new psychedelic drug treatment for alcohol addiction moving to clinical trial

As we all know alcohol addiction is one of the worst addictions in society costing billions per year. A 2010 […]